Randomized Phase 1/2 Evaluation of Neoadjuvant Administration of a Chemokine-Modulatory Regimen in Patients With Recurrent Resectable Colorectal Cancer
Phase of Trial: Phase I/II
Latest Information Update: 30 Jan 2018
At a glance
- Drugs Rintatolimod (Primary) ; Celecoxib; Interferon alpha-2b
- Indications Colorectal cancer
- Focus Pharmacogenomic; Therapeutic Use
- 24 Jan 2018 Status changed from recruiting to discontinued.
- 10 Jun 2017 Biomarkers information updated
- 02 Feb 2017 Planned End Date changed from 1 Aug 2017 to 1 Dec 2018.